doi: 10.1900/RDS.2011.8.369
Maryke Louw 5 min read bottom of page
A pragmatic trial period might be 812 weeks, during which weight, waist circumference, and any gastrointestinal symptoms should be monitored
While there may be some resistance to the conduction of clinical trials of pharmacological interventions in these clinical populations, the mechanistic profile of GLP-1RAs clearly suggests that these medications may play a role in the treatment of certain specific eating disorders, such as BED
But her experience in the ER being misdiagnosed because of her weight motivated her to change
They may have diabetes, dyslipidemia, or high blood pressure, so they are on multiple drugs